Revenue on a consolidated basis rose 23% year-on-year to ₹425 crore from ₹345 crore. EBITDA increased 73.4% to ₹108 crore, while margins improved to 25.4% from 18% a year ago. Shares of Metropolis Healthcare Ltd ended at ₹550, up by ₹2, or 0.36%, on the BSE today, May 13.
